As Xencor Ord (XNCR) Stock Rose, Shareholder Ecor1 Capital LLC Has Boosted Its Stake

Investors sentiment decreased to 1.5 in 2019 Q2. Its down 0.01, from 1.51 in 2019Q1. It turned negative, as 8 investors sold XNCR shares while 32 reduced holdings. 18 funds opened positions while 42 raised stakes. 46.43 million shares or 0.38% less from 46.61 million shares in 2019Q1 were reported. Jpmorgan Chase And invested in 0% or 230,474 shares. Swiss National Bank has 94,300 shares for 0% of their portfolio. Vanguard Group Inc holds 4.41M shares or 0.01% of its portfolio. Tekla Mgmt Ltd Llc has 72,382 shares. Renaissance Limited Co invested 0% of its portfolio in Xencor, Inc. (NASDAQ:XNCR). Chicago Equity Ptnrs Ltd Liability Com holds 12,105 shares. Spark Ltd Liability Corporation holds 0.02% or 8,400 shares in its portfolio. Barclays Public Limited Company reported 30,704 shares stake. Tocqueville Asset Management Lp owns 8,100 shares for 0% of their portfolio. Geode Mngmt Ltd accumulated 637,704 shares. Bankshares Of America Corp De holds 50,607 shares. Redmile Lc accumulated 1.61M shares. Virginia Retirement Sys Et Al stated it has 17,000 shares. Atria Ltd Llc invested in 0% or 10,519 shares. Fmr Ltd Com, a Massachusetts-based fund reported 8.45 million shares.

Since March 15, 2019, it had 3 insider purchases, and 0 insider sales for $978,109 activity.

Ecor1 Capital Llc increased its stake in Xencor Ord (XNCR) by 13.46% based on its latest 2019Q2 regulatory filing with the SEC. Ecor1 Capital Llc bought 277,128 shares as the company’s stock rose 46.93% . The institutional investor held 2.34M shares of the health care company at the end of 2019Q2, valued at $95.64 million, up from 2.06M at the end of the previous reported quarter. Ecor1 Capital Llc who had been investing in Xencor Ord for a number of months, seems to be bullish on the $1.96 billion market cap company. The stock decreased 0.28% or $0.1 during the last trading session, reaching $35.38. About 238,638 shares traded. Xencor, Inc. (NASDAQ:XNCR) has risen 23.34% since September 13, 2018 and is uptrending. It has outperformed by 23.34% the S&P500.

Ecor1 Capital Llc, which manages about $989.64 million US Long portfolio, decreased its stake in Mirati Therapeutics Ord (NASDAQ:MRTX) by 402,289 shares to 597,711 shares, valued at $61.56 million in 2019Q2, according to the filing. It also reduced its holding in Crispr Therapeutics Ord by 268,027 shares in the quarter, leaving it with 1.61 million shares, and cut its stake in Assembly Biosciences Ord (Call) (NASDAQ:ASMB).

Another recent and important Xencor, Inc. (NASDAQ:XNCR) news was published by which published an article titled: “Here’s What Hedge Funds Think About Xencor Inc (XNCR) – Yahoo Finance” on June 24, 2019.

Xencor, Inc. (NASDAQ:XNCR) Ratings Coverage

Among 3 analysts covering Xencor Inc (NASDAQ:XNCR), 2 have Buy rating, 1 Sell and 0 Hold. Therefore 67% are positive. Xencor Inc has $5200 highest and $21 lowest target. $40’s average target is 13.06% above currents $35.38 stock price. Xencor Inc had 9 analyst reports since March 14, 2019 according to SRatingsIntel. The stock of Xencor, Inc. (NASDAQ:XNCR) has “Buy” rating given on Thursday, March 14 by Raymond James. The stock has “Sell” rating by Nomura on Thursday, March 21. The stock has “Buy” rating by Canaccord Genuity on Thursday, August 8.

Xencor, Inc. (NASDAQ:XNCR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.